|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Bavarian Nordic (BAVA.CO) - Interim Report for the Period 1 January to 30 September 2011
11/16/2011 9:31:03 AM
KVISTGAARD, Denmark, Nov. 16, 2011 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (Copenhagen:BAVA) today announced its third quarter 2011 results. Revenue generated for the nine months ended September 30, 2011 were DKK 155 million, compared to DKK 219 million for the nine months ended September 30, 2010. For the nine months ended September 30, 2011, the Company reported a pre-tax loss of DKK 333 million compared to a pre-tax loss of DKK 386 million for the nine months ended September 30, 2010. The results are in line with expectations. As of 30 September 2011 the cash preparedness was DKK 632 million, including credit lines of DKK 120 million.
|
|
|
|
|
|
|
|
|
|
|